Trials / Completed
CompletedNCT05637229
A Serosurvey Study of Hand, Foot, and Mouth Disease in Indonesia
A Serosurvey Study of Hand, Foot, and Mouth Disease in Healthy Children Aged 6 to 71 Months Old in Bandung and West Bandung District, Indonesia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 600 (actual)
- Sponsor
- Sinovac Biotech Co., Ltd · Industry
- Sex
- All
- Age
- 6 Months – 71 Months
- Healthy volunteers
- Accepted
Summary
This study is a sero-survey study of infants aged 6 months to 71 months in Bandung City and West Bandung District. As initial data to find out how many children have been exposed to human enterovirus type 71 (HEV-71) which causes Hand, foot, and mouth disease (HFMD).
Detailed description
This study is a cross-sectional seroprevalence survey of EV-71, associated with HFMD, among children aged between 6 to 71 months in Bandung, sampled from urban and rural Primary Health Center in Bandung, Indonesia. This study was implemented by Department of Child Health Hasan Sadikin General Hospital/Medical Faculty Universitas Padjadjaran Bandung, West Java. Age-stratified sample of 600 children aged 6-71 months will be conducted from these sites. Samples testing includes routine blood counts, enzyme-linked immunosorbent assays (ELISAs) for enterovirus type 71 (EV71) IgG and ELISAs for other HFMD-associated enteroviruses.
Conditions
Timeline
- Start date
- 2022-11-28
- Primary completion
- 2022-12-19
- Completion
- 2022-12-19
- First posted
- 2022-12-05
- Last updated
- 2023-10-31
Locations
2 sites across 1 country: Indonesia
Source: ClinicalTrials.gov record NCT05637229. Inclusion in this directory is not an endorsement.